Age Related Macular Degeneration Clinical Trial
Official title:
The Evaluation of Nutrition Status in Persons With Age-Related Macular Degeneration
Including eye health, nutrition plays a vital role for the sustainability of individuals
health life. There is an increasing global concern about the issues related with eye health.
In 2010, in order to take attention to these issues, World Health Organization (WHO) defined
the main reasons of vision disorders as refraction defects of eye diseases (43 %), cataract
(33 %), glaucoma (2 %), age-related macular degeneration (AMD) (1 %), diabetic retinopathy (1
%) and undetermined natural reasons (18 %). This report also stated the three biggest reasons
of blindness as cataract (51 %), glaucoma (8 %) and AMD (5 %).
AMD is a multi-factorial disease in which the genetic predisposition plays important role
with environmental factors and metabolic conditions, except for age. Especially cigarette is
the secondary important risk factor for dry-type AMD. In the Age Related Eye Disease Study
(AREDS), it was stated that AMD prevalence is higher in white races, compared with races
which are not white. At the same time, AREDS searched the effect of diet supplements on the
progression of AMD disease. In terms of the patients followed for six years, it was reported
that the formulation C and E vitamins, beta carotene and zinc decreased the progression risk
of AMD from middle levels to advanced levels by 34 %. In AREDS-2 study completed in 2012, it
was shown that the extraction of beta carotene from the formulation and the decrease of zinc
did not affect the progression rate of the disease. In the group using beta carotene,
including persons who were used to smoke but gave up at least one year ago, the rate of
becoming lung cancer was observed as substantially high. Moreover, the use of lutein and
zeaxanthin instead of beta carotene in the formula did not increase the risk of lung cancer.
In addition, it was shown that omega-3 fatty acids did not decrease risk progression.
In current data, the effect of the intake of carotenoid and antioxidant increased with diet
on AMD is not coherent. Likewise, the epidemiological evidences about the relation between
diet fat intake and AMD are contradictory. The consumption of fatty fish is related with
increased poly-unsaturated fatty acid intake and decreases the risk of AMD. However, it was
reported the high rate of total fat intake in other studies as risk factor for AMD. In
another study, there was not any important relation found between diet fat intake and AMD
occurrence after the correction of other variables. In the interventional AREDS-2 study, it
was reported that the additional intake of long-chain omega-3 poly-unsaturated fatty acids
did not have any beneficial effect.
The pathophysiological mechanism responsible from the possible relation between obesity and
AMD is not clearly known. There are various hypotheses about how obesity causes AMD. In the
first hypothesis, obesity can cause AMD after obesity increases systematic oxidative stress.
In the second hypothesis, obesity can play a role in AMD pathophysiology as the cause of
hyperleptinemia. The studies also prescribed that inflammation could play a role in the
progression of AMD and also showed that plasma fibrinogen and other inflammation indicators
could be related with late AMD. In Pathologies Oculaires Liées à l'Age (POLA) study made with
the participation of many Europeans, it was observed that the progression of late AMD
increased by two times in obese individuals and in early AMD, obesity did not affect the
progression of disease. In the treatment of this disease which have age-related progression,
proper nutrition, vitamin/mineral/supplement usage and the development of precautionary
strategies play an important role.
When compared with Body Mass Index (BMI), it was found that the measure of abdominal obesity
(waist/hip rate and waist circumference) was the better determinant of chronic diseases such
as diabetics and cardiovascular disease. Some evidences in the United States of America
indicated that the relation between waist/hip rate and AMD gave stronger results when
compared with the relation between BMI and AMD. For middle age cohort, after six years of
follow-up, a group of researchers reported that the decrease of waist/hip rate also decreased
the risk of AMD and the results were the same for waist circumference, even if the evidences
were weak. In another study, it was reported that the increase of waist/hip rate or waist
circumference also increased the progression of AMD.
This study was planned with the aim of determining the occurrence of AMD by evaluating
dietary total antioxidant capacity, diet components and some anthropometric measures of
individuals having age related macular degeneration (AMD). In the study, the possible effect
of nutrition on the occurrence of disease was evaluated by comparing healthy individuals with
dietary total antioxidant capacity and some anthropometric measures of individuals with AMD.
While being benefited from the results of previous studies, the sample size of the research
was type 1 error performance α=0.05 and type 2 error performance β=0.20. The power of the
test was taken as 1-β=0.80 and the power analysis was statistically made with NCCS PAS 11
program. 200 individuals voluntarily participated into the study as control group, including
100 patients diagnosed with AMD (50 women, 50 men) and 100 patients not diagnosed as AMD (50
women, 50 men).
Sociodemographic Variables The questionnaire form, prepared to determine socio-demographic
features of individuals participating in the research, was applied by the research with the
method of face-to-face interview. The socio-demographic features of individuals (gender, age,
occupation, educational status, health conditions), use of cigarettes and drugs was
questioned.
Anthropometric Variables The body weight of the individuals were measured with a calibrated
electronic scale, which could measure even 0.1 kg, while the individuals were hungry, in
light clothes and their shoes were taken off. The body lengths were measured by the
researcher with the tape measure while they were standing upright in Frankfurt plane position
(ear canal and lower margin of orbit in the same horizontal plane, facing forward). BMI was
calculated with the formula [body weight (kg)/body length (m2)]. BMI evaluation was made
while the classification developed by World Health Organization (WHO) was taken as a basis
(13). According to this classification; (BMI<18.5 kg/m2 thin, 18.5< 24.9 kg/m2 normal,
25.0-29.9 kg/m2 overweight and ≥30 kg/m2 obese. The waist circumference of the individuals
was measured with tape measure by founding the midpoint between the lowest rib and umbilicus.
The relation between waist circumference and chronic diseases is as follows: If the waist
circumference is ≥88 cm for women and ≥102 cm for men, it is shown as high risk. The hip
circumference of the individuals was measured with a tape measure from the highest point by
standing the left side of the individuals. If the waist/hip rate is over 0.85 for women and
over 0.90 for men, the risk of chronic diseases increases.
Assesment of dietary intake and diet total antioxidant capacity Participants' dietary intake
was assessed using food frequency questionnaire (FFQ). The FFQ included 65 food items
traditionally consumed in Turkey. Foods were classified into the following food categories:
milk and dairy products, meat and meat products, fruits, vegetables, breads and cereals,
beverages, and desserts. Intake frequencies for the food items consisted of eight categories
ranging from never/once a month to more than one per day. Trained interviewers asked
participants how often they had consumed one portion of each food item in generally. To
compute the total amount of food intake per day, the reported frequency of consumption for
each food item was multiplied by the portion size and then total food intake was converted to
nutrient intake based on the food's nutrient profile. Standardized food recipes for Turkey
and Nutrition Information System (BEBIS) program which is a food composition database for
nutrient estimation were used to determine average daily energy and nutrient intake for each
participant. These values were compared with the recommended daily allowance values to
determine the energy and nutrient requirement meeting status and the requirement meeting
percentages were calculated.
By using food intake frequency amounts, dietary total antioxidant capacity was tried to be
determined approximately with the use of data obtained from a large-scale study made by
Carlsen for developing a database including total antioxidant component of essential
nutrients. The antioxidant amount in 100 g food given for each nutrient group in the related
resource was used as standard antioxidant activity value in this study and the approximate
antioxidant activity values of the grouped food intake amounts of individuals were
calculated.
Statistical Analysis In the statistical evaluation of data obtained from the study,
Statistical Package for Social Science (SPSS) 22.0 program was used. For the data obtained
from the measures of individuals participating in the study, average, standard deviation and
the lowest and the highest values were calculated. The distribution of data determined with
numbers was given with number-percentage tables. While evaluating constant data, it was
determined with Kolmogorov Smirnov test whether there was normal distribution or not. The
data of individuals having normal distribution were analyzed with parametric statistical
tests and the data of individuals not having normal distribution were analyzed with
non-parametric statistical tests. Odds ratios (OR) and 95% confidence intervals (CI) were
calculated by univariate logistic regression analysis separately for food group, BMI, and
adjusted age, gender before combined in multivariate logistic regression. Logistic regression
analysis was performed to determine risk factors for AMD using odds ratio estimates with 95%
confidence intervals. Furthermore, a stepwise multivariate regression analysis was performed,
with p value less than 0.05 being required for entering the model and remaining there.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03963817 -
Snapshot Camera for AMD
|
||
Recruiting |
NCT04929756 -
Eye Movement Rehabilitation in Low Vision Patients
|
||
Completed |
NCT04779398 -
Association of MPOD Values With Blue Light.
|
||
Terminated |
NCT03275753 -
Visual Function Tests in Age-related Macular Degeneration
|
||
Recruiting |
NCT03609307 -
Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial
|
Phase 2/Phase 3 | |
Completed |
NCT02909985 -
Visual Activity Evoked by Infrared in Humans After Dark Adaptation
|
N/A | |
Completed |
NCT02556723 -
Intravitreal Injections of Ziv-aflibercept for Macular Diseases
|
N/A | |
Active, not recruiting |
NCT01943396 -
Treatment of AMD With Rheohemapheresis /RHF/
|
Phase 4 | |
Completed |
NCT00963339 -
Age-Related Macular Degeneration (AMD) - Usability Study
|
N/A | |
Completed |
NCT00376701 -
Combination Therapy for Age-Related Macular Degeneration.
|
Phase 2 | |
Completed |
NCT00800995 -
Superoxide Dismutase (SOD) as Antioxidant Treatment OF Age Related Macular Degeneration (ARMD)
|
Phase 3 | |
Terminated |
NCT00347165 -
Intravitreal Bevacizumab for Age-Related Macular Degeneration
|
Phase 2 | |
Completed |
NCT04689789 -
OCTA and Retinal Angiomatous Proliferation
|
||
Completed |
NCT02567604 -
Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective
|
||
Completed |
NCT02173496 -
Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR)
|
||
Recruiting |
NCT01991730 -
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients
|
N/A | |
Active, not recruiting |
NCT01657669 -
Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results
|
Phase 4 | |
Completed |
NCT00776763 -
Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab
|
Phase 2 | |
Completed |
NCT00791570 -
Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy
|
Phase 1 | |
Completed |
NCT00413829 -
Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)
|
Phase 2 |